Biopharmaceutical Drug Design and Development
Editat de Susanna Wu-Pong, Yon Rojanasakulen Limba Engleză Hardback – 6 iun 2008
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 1047.59 lei 38-45 zile | |
Humana Press Inc. – 9 dec 2010 | 1047.59 lei 38-45 zile | |
Hardback (1) | 1274.81 lei 6-8 săpt. | |
Humana Press Inc. – 6 iun 2008 | 1274.81 lei 6-8 săpt. |
Preț: 1274.81 lei
Preț vechi: 1341.90 lei
-5% Nou
Puncte Express: 1912
Preț estimativ în valută:
244.05€ • 253.68$ • 202.34£
244.05€ • 253.68$ • 202.34£
Carte tipărită la comandă
Livrare economică 07-21 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781588297167
ISBN-10: 1588297160
Pagini: 388
Ilustrații: X, 375 p. 30 illus., 3 illus. in color.
Dimensiuni: 152 x 229 x 30 mm
Greutate: 0.74 kg
Ediția:2nd ed. 2008
Editura: Humana Press Inc.
Colecția Humana
Locul publicării:Totowa, NJ, United States
ISBN-10: 1588297160
Pagini: 388
Ilustrații: X, 375 p. 30 illus., 3 illus. in color.
Dimensiuni: 152 x 229 x 30 mm
Greutate: 0.74 kg
Ediția:2nd ed. 2008
Editura: Humana Press Inc.
Colecția Humana
Locul publicării:Totowa, NJ, United States
Public țintă
ResearchCuprins
Biotechnology: 2008 and Beyond.- The Human Genome Project and Drug Development.- The Use of Bioinformatics and Chemogenomics in Drug Discovery.- DNA Microarrays in Drug Discovery and Development.- Microarray Technology Using Proteins, Cells, and Tissues.- Pharmacogenetic Issues in Biopharmaceutical Drug Development.- Development and Applications of Transgenics in Biotechnology and Medicine.- Viral, Nonviral, and Physical Methods for Gene Delivery.- Stem Cell Technology and Drug Development.- Small Nucleic Acid-Based Drugs: Successes and Pitfalls.- Therapeutic Strategies Targeting the Innate Antiviral Immune Response.- Pharmacogenetics in the Clinic.- Molecular Modeling: Considerations for the Design of Pharmaceuticals and Biopharmaceuticals.- Macromolecular Drug Delivery.- Changes in Biologic Drug Approval at FDA.- Follow-On Protein Products: The Age of Biogenerics?.
Recenzii
From the reviews of the second edition:
"The book comprises 16 chapters written by 24 authors from academic and industrial laboratories in the U.S. The book is suitable for a wide audience of industrial and academic pharmaceutical scientists interested in a broad introduction to biopharmaceutical technology within the context of drug design and development. … Overall, the book is well written with an excellent nine-page index. The chapters are generally well illustrated. … it would be a valuable addition to industrial and academic libraries." (Aliasger K. Salem, Journal of Medicinal Chemistry, Vol. 51 (19), 2008)
"This book is an update of the first edition of Biopharmaceutical Drug Development … . this book is dedicated to quite detailed discussion of the impact the various ‘omic’ technologies have had on drug discovery and design. … Overall, this is quite a useful reference book for toxicologists working in the biopharmaceutical sector, particularly if they are still getting to grips with the various ‘omics’ technologies and areas such stem cell therapy and gene silencing." (Peter Ryle, British Toxicological Society Newsletter, June-August, 2009)
"The book comprises 16 chapters written by 24 authors from academic and industrial laboratories in the U.S. The book is suitable for a wide audience of industrial and academic pharmaceutical scientists interested in a broad introduction to biopharmaceutical technology within the context of drug design and development. … Overall, the book is well written with an excellent nine-page index. The chapters are generally well illustrated. … it would be a valuable addition to industrial and academic libraries." (Aliasger K. Salem, Journal of Medicinal Chemistry, Vol. 51 (19), 2008)
"This book is an update of the first edition of Biopharmaceutical Drug Development … . this book is dedicated to quite detailed discussion of the impact the various ‘omic’ technologies have had on drug discovery and design. … Overall, this is quite a useful reference book for toxicologists working in the biopharmaceutical sector, particularly if they are still getting to grips with the various ‘omics’ technologies and areas such stem cell therapy and gene silencing." (Peter Ryle, British Toxicological Society Newsletter, June-August, 2009)
Textul de pe ultima copertă
Biopharmaceutical Drug Design and Development, Second Edition, updates the widely successful first edition, published in 1999. This new, expanded edition investigates the dozens of new biopharmaceutical drugs that have become available since the publication of the first edition. Among the drugs discussed are ones in the categories of monoclonal antibodies for in-vivo use, cytokines, growth factors, enzymes, immunomodulators, thrombolytics, and immonotherapies including vaccines. Additionally, the volume examines new and emerging technologies, such as bioinformatics, DNA microarrays, transgenics, therapeutic gene delivery, stem cells, nucleic acid-based therapeutics, and macromolecular drug delivery. Authors also study pharmacogenetics in the clinic and changes in biologic drug approval at the FDA. Biopharmaceutical Drug Design and Development, Second Edition, is a worthy sequel in the discussion on the dynamic, exciting field of biotechnology.
Caracteristici
Comprehensive examination of the newest biopharmaceutical drugs Detailed investigation of revolutionary inventions and techniques, including cloning and microarray technology Review of the Human Genome Project